NEW YORK (Reuters) – Johnson & Johnson (NYSE:) agreed to pay about $230 million to resolve claims it helped fuel an opioid crisis in New York, the state’s attorney general said on Saturday.
The agreement addresses claims brought by Attorney General Letitia James, and will remove Johnson & Johnson as a defendant in a broader trial over opioids scheduled to begin next week.
J&J did not admit liability or wrongdoing in agreeing to settle. It said the agreement was consistent with its prior agreement to pay $5 billion to settle opioid claims by states, cities, counties and tribal governments nationwide.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Need Your Help Today. Your $1 can change life.